![]() The issue could be particularly significant in cases where there was a potential third-party guilt defense, but no interpretable DNA profile was developed during testing. ![]() It appears that NMS Labs has provided notice of the issue in impacted cases and that the notice is being provided to defense attorneys by district attorney offices, but attorneys who have pending or resolved cases where NMS Labs performed DNA analysis from approximately 2016-2018 should review their cases. The amplification inhibitor can also result in the failure to reveal additional low level contributor(s) in a mixed sample. The amplification inhibitor may result in failure to develop DNA profiles from samples that would otherwise be expected to yield a full or partial interpretable DNA profile. The issue that has been identified is the presence of an amplification inhibitor from the use of a particular DNA purification kit. DA’s offices in various jurisdictions have sent samples to NMS Labs for DNA testing in recent years. Attorneys from several counties have received notice through discovery that their cases were potentially affected by a DNA testing issue at National Medical Services (NMS) Labs in Pennsylvania.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |